BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Porton Advanced and TongEYE Partner to Accelerate iPSC-Derived Cell Therapy for Blinding Eye Diseases

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

May 23, 2025 | News

KFSHRC and Cellenkos Join Forces to Launch First Saudi-U.S. Clinical Trials for Treg Cell Therapies

KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host Disease Cellenkos to Support Local Cell and Gene Therapy Manufacturing at&nb...

May 23, 2025 | News

AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders

-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...

May 19, 2025 | News

Thermo Fisher Scientific Opens Malaysia Commercial HQ to Advance Scientific Innovation in Asia Pacific

Thermo Fisher Scientific, the world leader in serving science, celebrated the grand opening of its new Malaysia Commercial Headquarters in Shah Alam, reinf...

May 19, 2025 | News

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 to Include Brain-Derived pTau Assays for Alzheimer’s and Tauopathy Research

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAse...

May 16, 2025 | News

Agilent and Ubix Therapeutics Join Forces to Advance Targeted Cancer Therapies in South Korea

Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies ...

May 15, 2025 | News

BD Launches FACSDiscover™ A8 Cell Analyzer to Expand Access to Advanced Spectral and Real-Time Imaging Technologies

New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma BD (Becton...

May 14, 2025 | News

EnGeneIC Doses First Patient in Phase I/IIa Trial for EGFR-Positive Solid Tumours at Mater Hospital, Sydney

First Patient dosed in Phase I/IIa Basket Trial for Solid Tumours at Mater Hospital, North Sydney Recruitment to open this month at Frankston Hospital, ...

May 13, 2025 | News

Roche and Genentech Invest $700M in First U.S. East Coast Facility to Advance Obesity Drug Manufacturing

Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio $700+ million investm...

May 13, 2025 | News

Leica Microsystems Launches Visoria Series to Streamline Routine Microscopy Across Life Science and Industry

Leica Microsystems, a leading provider of microscopy and scientific instrumentation, has launched the Visoria series of upright microscopes, to help enhanc...

May 08, 2025 | News

Flagship Pioneering Partners with NUS Medicine, NUH, and NUHS to Drive Global Life Science Innovation from Singapore

Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability Flagship Pioneering, the ...

May 07, 2025 | News

IGI’s Trispecific Antibody ISB 2001 Receives FDA Fast Track Designation for Relapsed Multiple Myeloma

IGI, a global, fully integrated, clinical-stage biotechnology company focused on multi-species™ oncology product development, announced that th...

May 06, 2025 | News

Thermo Fisher to Invest $2 Billion in U.S. Manufacturing and Innovation Expansion

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next fou...

April 25, 2025 | News

Beckman Coulter Launches OptiMATE Gradient Maker to Speed Up Ultracentrifugation Workflows

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient...

April 24, 2025 | News

Stay Connected